Evaluation of the real time HIV-1, xpert HIV-1, and aptima HIV-1 quant dx assays in comparison to the nucli sens EasyQ HIV-1 v2.0 assay for quantification of HIV-1 viral load

Journal of Clinical Microbiology

Volumn 53, Issue 11, 2015, Pages 3458-3465

  Mor, Orna ^a   Gozlan, Yael ^a   Wax, Marina ^a   Mileguir, Fernando ^a   Rakovsky, Avia ^a   Noy, Bina ^b   Mendelson, Ella ^a,c   Levy, Itzchak ^d  

^a MINISTRY OF HEALTH   (Israel)

^b Ilex Medical   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASSAY; CONTROLLED STUDY; CORRELATION COEFFICIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LIMIT OF QUANTITATION; MEASUREMENT ACCURACY; MEASUREMENT PRECISION; NONHUMAN; PRIORITY JOURNAL; RAPID TEST; REPRODUCIBILITY; VIRUS DETECTION; VIRUS LOAD; BIOASSAY; BLOOD; COMPARATIVE STUDY; DIAGNOSTIC KIT; EVALUATION STUDY; GENETICS; HIV INFECTIONS; MOLECULAR DIAGNOSIS; PROCEDURES; SENSITIVITY AND SPECIFICITY; VIROLOGY;

DIAGNOSTIC KIT; VIRUS RNA;

BIOLOGICAL ASSAY; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; REAGENT KITS, DIAGNOSTIC; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 84945193088     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01806-15     Document Type: Article

References (24)

1. Thompson MA, Aberg JA, Hoy JF, Telenti A, Benson C, Cahn P, Eron JJ, Gunthard HF, Hammer SM, Reiss P, Richman DD, Rizzardini G, Thomas DL, Jacobsen DM, Volberding PA. 2012. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA 308:387-402.
2. World Health Organization. 2013. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. World Health Organization, Geneva, Switzerland. http://www.who.int/hiv/pub/guidelines/arv2013.
3. Doyle T, Smith C, Vitiello P, Cambiano V, Johnson M, Owen A, Phillips AN, Geretti AM. 2012. Plasma HIV-1 RNA detection below 50 copies/ml and risk of virologic rebound in patients receiving highly active antiretroviral therapy. Clin Infect Dis 54:724-732. http://dx.doi.org/10.1093/cid/cir936.
4. Senechal B, James VL. 2012. Ten years of external quality assessment of human immunodeficiency virus type 1 RNA quantification. J Clin Microbiol 50:3614-3619. http://dx.doi.org/10.1128/JCM.01221-12.
5. Wainberg MA. 2004. HIV-1 subtype distribution and the problem of drug resistance. AIDS 18(Suppl 3):S63-S68.
6. Abecasis AB, Wensing AM, Paraskevis D, Vercauteren J, Theys K, Van de Vijver DA, Albert J, Asjo B, Balotta C, Beshkov D, Camacho RJ, Clotet B, De Gascun C, Griskevicius A, Grossman Z, Hamouda O, Horban A, Kolupajeva T, Korn K, Kostrikis LG, Kucherer C, Liitsola K, Linka M, Nielsen C, Otelea D, Paredes R, Poljak M, Puchhammer-Stockl E, Schmit JC, Sonnerborg A, Stanekova D, Stanojevic M, Struck D, Boucher CA, Vandamme AM. 2013. HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics. Retrovirology 10:7. http://dx.doi.org/10.1186/1742-4690-10-7.
7. Liu TF, Shafer RW. 2006. Web resources for HIV type 1 genotypic-resistance test interpretation. Clin Infect Dis 42:1608-1618. http://dx.doi.org/10.1086/503914.
8. Xu S, Song A, Nie J, Li X, Wang Y. 2010. Performance of NucliSens HIV-1 EasyQ Version 2.0 compared with six commercially available quantitative nucleic acid assays for detection of HIV-1 in China. Mol Diagn Ther 14:305-316. http://dx.doi.org/10.1007/BF03256386.
9. Garcia-Diaz A, Clewley GS, Booth CL, Labett W, McAllister N, Geretti AM. 2006. Comparative evaluation of the performance of the Abbott real-time human immunodeficiency virus type 1 (HIV-1) assay for measurement of HIV-1 plasma viral load following automated specimen preparation. J Clin Microbiol 44:1788-1791. http://dx.doi.org/10.1128/JCM.44.5.1788-1791.2006.
10. Bland JM, Altman DG. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet i:307-310.
11. Verbeke G, Molenberghs G. 2000. Linear mixed models for longitudinal data. Springer-Verlag, New York, NY
12. Sollis KA, Smit PW, Fiscus S, Ford N, Vitoria M, Essajee S, Barnett D, Cheng B, Crowe SM, Denny T, Landay A, Stevens W, Habiyambere V, Perrins J, Peeling RW. 2014. Systematic review of the performance of HIV viral load technologies on plasma samples. PLoS One 9:e85869. http://dx.doi.org/10.1371/journal.pone.0085869.
13. Panel on Antiretroviral Guidelines for Adults and Adolescents. 2015. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services, Washington, DC. http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescent GL.pdf
14. Yan CS, Hanafi I, Kelleher AD, Carr AD, Amin J, McNally LP, Cunningham PH. 2010. Lack of correlation between three commercial platforms for the evaluation of human immunodeficiency virus type 1 (HIV-1) viral load at the clinically critical lower limit of quantification. J Clin Virol 49:249-253. http://dx.doi.org/10.1016/j.jcv.2010.08.016.
15. Xu S, Song A, Nie J, Li X, Meng S, Zhang C, Wang Y. 2012. Comparison between the automated Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 assay and its version 1 and Nuclisens HIV-1 EasyQ version 2.0 assays when measuring diverse HIV-1 genotypes in China. J Clin Virol 53:33-37. http://dx.doi.org/10.1016/j.jcv.2011.10.001.
16. Amendola A, Marsella P, Bloisi M, Forbici F, Angeletti C, Capobianchi MR. 2014. Ability of two commercially available assays (Abbott RealTime HIV-1 and Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 Version 2.0) to quantify low HIV-1 RNA levels (< 1, 000 copies/milliliter): comparison with clinical samples and NIBSC working reagent for nucleic acid testing assays. J Clin Microbiol 52:2019-2026. http://dx.doi.org/10.1128/JCM.00288-14.
17. Naeth G, Ehret R, Wiesmann F, Braun P, Knechten H, Berger A. 2013. Comparison of HIV-1 viral load assay performance in immunological stable patients with low or undetectable viremia. Med Microbiol Immunol 202:67-75. http://dx.doi.org/10.1007/s00430-012-0249-y.
18. Bourlet T, Signori-Schmuck A, Roche L, Icard V, Saoudin H, Trabaud MA, Tardy JC, Morand P, Pozzetto B, Ecochard R, Andre P. 2011. HIV-1 load comparison using four commercial real-time assays. J Clin Microbiol 49:292-297. http://dx.doi.org/10.1128/JCM.01688-10.
19. Katsoulidou A, Rokka C, Issaris C, Haida C, Tzannis K, Sypsa V, Detsika M, Paraskevis D, Hatzakis A. 2011. Comparative evaluation of the performance of the Abbott RealTime HIV-1 assay for measurement of HIV-1 plasma viral load on genetically diverse samples from Greece. Virol J 8:10. http://dx.doi.org/10.1186/1743-422X-8-10.
20. Scott LE, Noble LD, Moloi J, Erasmus L, Venter WD, Stevens W. 2009. Evaluation of the Abbott m2000 RealTime human immunodeficiency virus type 1 (HIV-1) assay for HIV load monitoring in South Africa compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV-1, and BioMerieux Nu-cliSENS EasyQ HIV-1 assays. J Clin Microbiol 47:2209-2217. http://dx.doi.org/10.1128/JCM.01761-08.
21. Swenson LC, Cobb B, Geretti AM, Harrigan PR, Poljak M, Seguin-Devaux C, Verhofstede C, Wirden M, Amendola A, Boni J, Bourlet T, Huder JB, Karasi JC, Zidovec Lepej S, Lunar MM, Mukabayire O, Schuurman R, Tomazic J, Van Laethem K, Vandekerckhove L, Wensing AM. 2014. Comparative performances of HIV-1 RNA load assays at low viral load levels: results of an international collaboration. J Clin Microbiol 52:517-523. http://dx.doi.org/10.1128/JCM.02461-13.
22. Gomes P, Carvalho AP, Diogo I, Goncalves F, Costa I, Cabanas J, Camacho RJ. 2013. Comparisonof the NucliSENS EasyQ HIV-1 v2.0 with Abbott m2000rt RealTime HIV-1 assay for plasma RNA quantitation in different HIV-1 subtypes. J Virol Methods 193:18-22. http://dx.doi.org/10.1016/j.jviromet.2013.05.001.
23. Muenchhoff M, Madurai S, Hempenstall AJ, Adland E, Carlqvist A, Moonsamy A, Jaggernath M, Mlotshwa B, Siboto E, Ndung'u T, Goul-der PJ. 2014. Evaluation of the NucliSens EasyQ v2.0 assay in comparison with the Roche Amplicor v1.5 and the Roche CAP/CTM HIV-1 Test v2.0 in quantification of C-clade HIV-1 in plasma. PLoS One 9:e103983. http://dx.doi.org/10.1371/journal.pone.0103983.
24. Ndiaye O, Diop-Ndiaye H, Ouedraogo AS, Fall ZM, Sall-Sow A, Thiam M, Diouara AA, Ndour CT, Gaye-Diallo A, Mboup S, Toure-Kane C. 2015. Comparison of four commercial viral load techniques in an area of non-B HIV-1 subtypes circulation. J Virol Methods 222:122-131. http://dx.doi.org/10.1016/j.jviromet.2015.06.002.